Kristina Kriksciukaite
Director, DMPK at Agios Pharmaceuticals- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Linda Custer
Kristina is both a brilliant scientist and an enjoyable and supportive colleague. Kristina has broad experience in supporting both drug discovery and development bench top efforts and laboratory efforts related to ongoing human clinical studies. She is comfortable as an individual contributor in the laboratory, developing, executing, and reporting on studies. She is also an effective supervisor, interviewing, hiring, and training staff, and seeing that they perform to their maximum potential and continue to grow. Her coaching and development abilities ensure that her staff is continuously motivated by real achievement. She is highly skilled in organizing and executing DMPK and toxicokinetic studies as well as animal studies and myriad general molecular and biological assays, organizing these to provide complete support as target products move from concept through clinical proof. She commands skills to operate these studies in house or to acquire quotes and productively manage studies through vendors. She contributes actively to scientific discussions with her colleagues, frequently offering insights that have significant positive impact on program speed, direction, and coherence. She is a clear, precise, and powerful speaker and writer. One of Kristina's most valuable superpowers is her ability to move her knowledge across disciplines with great agility and to take on new tasks and discovery areas without missing a beat. She learns exceptionally quickly, is unfailingly curious, and excels at separating out what is important from what is unnecessary. She never hesitates to take on projects where she can combine her formidable background with new areas, even when she has not worked in those areas previously. She has demonstrated that she can take over projects from her colleagues, even when they are not fully aligned with her background, and not only maintain them but improve them significantly. Kristina is easy to work with. She immediately improves the environment within any team she joins. She develops relationships easily with her colleagues that are trusting and nurturing. She listens well, carries more than her share of any joint tasks, and re-enforces colleagues doing the right thing while finding ways to re-direct colleagues who are more challenged so that those colleagues become more productive while feeling good about their role and performance.
Mark Bilodeau
Kristina is consistently a top contributor and leader who was responsible for many key activities at Tarveda. Kristina always embodies an extraordinary level of commitment and ownership. She led all of the DMPK activities for the organization; managing preclinical programs and also owning Tarveda’s clinical pharmacology efforts for our two molecules that completed Phase 2 studies. Despite the demands of these responsibilities, she was always ready to help whenever she saw any other need in the organization, for example, contributing at key times to the management of translational biology studies. She consistently builds strong relationships with all her colleagues and is a very strong manager of external CRO activities. She also very effectively managed a range of consultants to ensure the successful progression of the clinical pharmacology studies for our clinical molecules. Kristina was always a key talent and leader for Tarveda and was a widely valued and respected colleague with exceptional commitment to our common goals.
Linda Custer
Kristina is both a brilliant scientist and an enjoyable and supportive colleague. Kristina has broad experience in supporting both drug discovery and development bench top efforts and laboratory efforts related to ongoing human clinical studies. She is comfortable as an individual contributor in the laboratory, developing, executing, and reporting on studies. She is also an effective supervisor, interviewing, hiring, and training staff, and seeing that they perform to their maximum potential and continue to grow. Her coaching and development abilities ensure that her staff is continuously motivated by real achievement. She is highly skilled in organizing and executing DMPK and toxicokinetic studies as well as animal studies and myriad general molecular and biological assays, organizing these to provide complete support as target products move from concept through clinical proof. She commands skills to operate these studies in house or to acquire quotes and productively manage studies through vendors. She contributes actively to scientific discussions with her colleagues, frequently offering insights that have significant positive impact on program speed, direction, and coherence. She is a clear, precise, and powerful speaker and writer. One of Kristina's most valuable superpowers is her ability to move her knowledge across disciplines with great agility and to take on new tasks and discovery areas without missing a beat. She learns exceptionally quickly, is unfailingly curious, and excels at separating out what is important from what is unnecessary. She never hesitates to take on projects where she can combine her formidable background with new areas, even when she has not worked in those areas previously. She has demonstrated that she can take over projects from her colleagues, even when they are not fully aligned with her background, and not only maintain them but improve them significantly. Kristina is easy to work with. She immediately improves the environment within any team she joins. She develops relationships easily with her colleagues that are trusting and nurturing. She listens well, carries more than her share of any joint tasks, and re-enforces colleagues doing the right thing while finding ways to re-direct colleagues who are more challenged so that those colleagues become more productive while feeling good about their role and performance.
Mark Bilodeau
Kristina is consistently a top contributor and leader who was responsible for many key activities at Tarveda. Kristina always embodies an extraordinary level of commitment and ownership. She led all of the DMPK activities for the organization; managing preclinical programs and also owning Tarveda’s clinical pharmacology efforts for our two molecules that completed Phase 2 studies. Despite the demands of these responsibilities, she was always ready to help whenever she saw any other need in the organization, for example, contributing at key times to the management of translational biology studies. She consistently builds strong relationships with all her colleagues and is a very strong manager of external CRO activities. She also very effectively managed a range of consultants to ensure the successful progression of the clinical pharmacology studies for our clinical molecules. Kristina was always a key talent and leader for Tarveda and was a widely valued and respected colleague with exceptional commitment to our common goals.
Linda Custer
Kristina is both a brilliant scientist and an enjoyable and supportive colleague. Kristina has broad experience in supporting both drug discovery and development bench top efforts and laboratory efforts related to ongoing human clinical studies. She is comfortable as an individual contributor in the laboratory, developing, executing, and reporting on studies. She is also an effective supervisor, interviewing, hiring, and training staff, and seeing that they perform to their maximum potential and continue to grow. Her coaching and development abilities ensure that her staff is continuously motivated by real achievement. She is highly skilled in organizing and executing DMPK and toxicokinetic studies as well as animal studies and myriad general molecular and biological assays, organizing these to provide complete support as target products move from concept through clinical proof. She commands skills to operate these studies in house or to acquire quotes and productively manage studies through vendors. She contributes actively to scientific discussions with her colleagues, frequently offering insights that have significant positive impact on program speed, direction, and coherence. She is a clear, precise, and powerful speaker and writer. One of Kristina's most valuable superpowers is her ability to move her knowledge across disciplines with great agility and to take on new tasks and discovery areas without missing a beat. She learns exceptionally quickly, is unfailingly curious, and excels at separating out what is important from what is unnecessary. She never hesitates to take on projects where she can combine her formidable background with new areas, even when she has not worked in those areas previously. She has demonstrated that she can take over projects from her colleagues, even when they are not fully aligned with her background, and not only maintain them but improve them significantly. Kristina is easy to work with. She immediately improves the environment within any team she joins. She develops relationships easily with her colleagues that are trusting and nurturing. She listens well, carries more than her share of any joint tasks, and re-enforces colleagues doing the right thing while finding ways to re-direct colleagues who are more challenged so that those colleagues become more productive while feeling good about their role and performance.
Mark Bilodeau
Kristina is consistently a top contributor and leader who was responsible for many key activities at Tarveda. Kristina always embodies an extraordinary level of commitment and ownership. She led all of the DMPK activities for the organization; managing preclinical programs and also owning Tarveda’s clinical pharmacology efforts for our two molecules that completed Phase 2 studies. Despite the demands of these responsibilities, she was always ready to help whenever she saw any other need in the organization, for example, contributing at key times to the management of translational biology studies. She consistently builds strong relationships with all her colleagues and is a very strong manager of external CRO activities. She also very effectively managed a range of consultants to ensure the successful progression of the clinical pharmacology studies for our clinical molecules. Kristina was always a key talent and leader for Tarveda and was a widely valued and respected colleague with exceptional commitment to our common goals.
Linda Custer
Kristina is both a brilliant scientist and an enjoyable and supportive colleague. Kristina has broad experience in supporting both drug discovery and development bench top efforts and laboratory efforts related to ongoing human clinical studies. She is comfortable as an individual contributor in the laboratory, developing, executing, and reporting on studies. She is also an effective supervisor, interviewing, hiring, and training staff, and seeing that they perform to their maximum potential and continue to grow. Her coaching and development abilities ensure that her staff is continuously motivated by real achievement. She is highly skilled in organizing and executing DMPK and toxicokinetic studies as well as animal studies and myriad general molecular and biological assays, organizing these to provide complete support as target products move from concept through clinical proof. She commands skills to operate these studies in house or to acquire quotes and productively manage studies through vendors. She contributes actively to scientific discussions with her colleagues, frequently offering insights that have significant positive impact on program speed, direction, and coherence. She is a clear, precise, and powerful speaker and writer. One of Kristina's most valuable superpowers is her ability to move her knowledge across disciplines with great agility and to take on new tasks and discovery areas without missing a beat. She learns exceptionally quickly, is unfailingly curious, and excels at separating out what is important from what is unnecessary. She never hesitates to take on projects where she can combine her formidable background with new areas, even when she has not worked in those areas previously. She has demonstrated that she can take over projects from her colleagues, even when they are not fully aligned with her background, and not only maintain them but improve them significantly. Kristina is easy to work with. She immediately improves the environment within any team she joins. She develops relationships easily with her colleagues that are trusting and nurturing. She listens well, carries more than her share of any joint tasks, and re-enforces colleagues doing the right thing while finding ways to re-direct colleagues who are more challenged so that those colleagues become more productive while feeling good about their role and performance.
Mark Bilodeau
Kristina is consistently a top contributor and leader who was responsible for many key activities at Tarveda. Kristina always embodies an extraordinary level of commitment and ownership. She led all of the DMPK activities for the organization; managing preclinical programs and also owning Tarveda’s clinical pharmacology efforts for our two molecules that completed Phase 2 studies. Despite the demands of these responsibilities, she was always ready to help whenever she saw any other need in the organization, for example, contributing at key times to the management of translational biology studies. She consistently builds strong relationships with all her colleagues and is a very strong manager of external CRO activities. She also very effectively managed a range of consultants to ensure the successful progression of the clinical pharmacology studies for our clinical molecules. Kristina was always a key talent and leader for Tarveda and was a widely valued and respected colleague with exceptional commitment to our common goals.
Experience
-
Agios Pharmaceuticals
-
United States
-
Pharmaceutical Manufacturing
-
300 - 400 Employee
-
Director, DMPK
-
Nov 2022 - Present
-
-
-
Tarveda Therapeutics
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Associate Director
-
Mar 2020 - Apr 2022
-
-
-
Tarveda Therapeutics
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Principal Scientist
-
Jan 2017 - Feb 2018
-
-
Scientist II
-
Aug 2013 - Jan 2017
-
-
-
-
Scientist I, DMPK
-
Jan 2011 - Jun 2013
-
-
-
Alkermes
-
Ireland
-
Biotechnology Research
-
700 & Above Employee
-
Senior Bioanalytical Analyst
-
1999 - Jan 2011
-
-